Bustos J, Barón J, Vargas L

Language: Spanish
References: 4
Page: 320-321
PDF size: 288.24 Kb.

Text Extraction

No abstract.

REFERENCES

1. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, BambakidisNC, Becker K, Biller J, Brown M, Demaerschalk BM,Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, OvbiageleB, Scott PA, Sheth KN, Southerland AM, Summers DV,Tirschwell DL; on behalf of the American Heart AssociationStroke Council. Guidelines for the early managementof patients with acute ischemic stroke: 2019 update tothe 2018 guidelines for the early management of acuteischemic stroke: a guideline for healthcare professionalsfrom the American Heart Association/American StrokeAssociation. Stroke 2019; 50: e344-e418 doi: 10.1161/STR.0000000000000211

2. Karen C. Johnston, Askiel Bruno, Qi Pauls, Christiana E.Hall, Kevin M. Barrett, William Barsan, et al. Intensivevs standard treatment of hyperglycemia and functionaloutcome in patients with acute ischemic stroke. The SHINERandomized Clinical Trial. JAMA 2019; 322 (4): 326-335.doi: 10.1001/jama.2019.9346

3. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ,Demaerschalk BM, Khatri P, McMullan PW Jr, Qureshi AI,Rosenfield K, Scott PA, Summers DR, Wang DZ, WintermarkM, Yonas H; on behalf of the American Heart AssociationStroke Council, Council on Cardiovascular Nursing, Councilon Peripheral Vascular Disease, and Council on Clinical Cardiology.Guidelines for the early management of patientswith acute ischemic stroke: a guideline for healthcare professionalsfrom the American Heart Association/AmericanStroke Association. Stroke 2013; 44: 870-947.

4. Bellolio F, Gilmore RM, Ganti L. Insulin for glycaemiccontrol in acute ischaemic stroke. Cochrane DatabaseSyst Rev 2014; 1: CD005346. doi:10.1002/14651858.CD005346.pub4